Nanobio and Nanomedicine

Oasmia Pharmaceutical AB develops next generation cancer drugs based on nanotechnology for human and veterinary use.

A protein biosensor company focused on the development of portable, electronic detection devices for use in in vitro diagnostics using nano-engineered electronic surfaces arrayed on disposable chips.

OmegaGenesis, Inc. is a biotechnology company that discovers and produces nano-scale materials that work on the cellular and sub-cellular level to promote or inhibit angiogenesis, the growth of new blood vessels.

Orla has patented, developed and commercialized a technology which radically simplifies the way in which proteins are immobilised on surfaces.

Oxford Nanopore Technologies Ltd is developing nanopore technology, a revolutionary method of molecular detection and analysis with potential applications in DNA sequencing, diagnostics, drug development and defence.